And I get accused of being on the cool aid, for my comments about the negative posts and the perception to potential investors in the US doing their research (never said Institutions LOL) into BLT.
You must be smoking crack! Why on earth would management consider a buyback without an income stream? Or not advance one of the other programmes, buy out Callimune?
Much better things with much more potential to the company than a buyback.
I think management started talking yesterday with that great announcement.
BLT Price at posting:
39.0¢ Sentiment: Buy Disclosure: Held